Basis of Presentation and Significant Accounting Policies (Tables)

9 Months Ended

Sep. 28, 2018

Schedule Of Cash And Cash Equivalents And Restricted Cash Equivalents [Table Text Block]

The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the condensed Consolidated Balance Sheets that sum to the total of the same such amounts shown in the Condensed Consolidated Statements of Cash Flows (in 000’s):

	September 28, 2018		December 29, 2017		September 29, 2017
Cash and cash equivalents	$	102,195	$	18,520	$	16,133
Restricted cash included in other long-term assets		121		121		120
Total cash, cash equivalents and restricted cash as shown in the Consolidated Statements of Cash Flows	$	102,316	$	18,641	$	16,253

Estimated Sales Return [Table Text Block]

On the Condensed Consolidated Balance Sheets, the balances associated for estimated sales returns are as follows:

	September 28, 2018		December 29, 2017
Estimated returns - inventory (1)	$	678	$	534
Allowance for sales returns		2,802		2,546

(1)	Recognized in inventories, net on the Condensed Consolidated Balance Sheets

Royalty Income [Table Text Block]

The Company recognizes the revenue at a point-in-time, typically quarterly based on various factors including information from the licensee, historical performance and contract minimums; royalty income was as follows (in thousands):

	Three Months Ended				Nine Months Ended
	September 28, 2018		September 29, 2017		September 28, 2018		September 29, 2017
Royalty income (1)	$	159	$	141	$	465	$	400

(1)

Shown as a separate line item in other income, net on the Condensed Consolidated Statements of Operations.

Condensed Financial Statements [Table Text Block]

The following table summarizes the impact of adopting Topic 606 on the Company’s Condensed Consolidated Balance Sheets for September 28, 2018 (in 000’s) (see also Note 14):

	As Reported		Adjustments			Balances ‎ without the ‎ adoption of ‎ 606
Accounts receivable trade, net	$	23,732	$	(2,802	)	$	20,930
Total current assets		147,297		(2,802	)		144,495
Total assets		162,988		(2,802	)		160,186
Allowance for sales returns		2,802		(2,802	)		—
Total current liabilities		27,540		(2,802	)		24,738
Total liabilities		34,124		(2,802	)		31,322
Total liabilities and stockholders’ equity		162,988		(2,802	)		160,186